Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610838 · ClinicalTrials.gov registry record
Effects of E-cigarette Use on Health
A clinical trial of Electronic Cigarette Use, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT06610838: Recruiting study of Electronic Cigarette Use, sponsored by University of Wisconsin, Madison.
NCT06610838 is a study of Electronic Cigarette Use that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 600 participants, above the 173-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (247% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06610838, a study of Electronic Cigarette Use, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Electronic nicotine delivery systems (ENDS) are used by millions of Americans, however their long-term health effects are unknown. This research proposal will quantify the effects of long-term ENDS use on validated and novel biomarkers of cardiovascular and pulmonary disease and how they are influenced by use heaviness, age, body weight, and co-use of other products. This study will produce the most informative evidence to date on how long-term ENDS use affects cardiovascular and pulmonary health.
Primary Outcome
Carotid ultrasound CCA-IMT measures the thickness of the carotid artery wall and is a measure of arterial injury. Rates of change vary by age, sex, and race, but less increase is associated with less cardiovascular disease risk.
Conditions Studied
Interventions
- OTHER Health Assessments
Study Locations (1)
Wisconsin
- UW Center for Tobacco Research and Intervention - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2029-06-30 |
What NCT06610838 shows while recruiting
NCT06610838 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 173-participant average among 15 other Electronic Cigarette Use trials with a reported enrollment target (247% higher).
The record links to 1 condition, with Electronic Cigarette Use appearing as the primary indexed condition, and to 1 intervention - of which Health Assessments is the first listed.
NCT06610838 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06610838 about?
NCT06610838 is a clinical study titled "Effects of E-cigarette Use on Health". Electronic nicotine delivery systems (ENDS) are used by millions of Americans, however their long-term health effects are unknown. This research proposal will quantify the effects of long-term ENDS use on validated and novel biomarkers of cardiovascular and pulmonary disease and how they are influen...
What is the current status of trial NCT06610838?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2025-01-06. Estimated completion is 2029-06-30.
What conditions does trial NCT06610838 study?
This clinical trial studies the following conditions: Electronic Cigarette Use.
What interventions are being tested in trial NCT06610838?
The interventions under investigation include: Health Assessments (OTHER).
Who is sponsoring clinical trial NCT06610838?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06610838 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06610838's enrollment target sits among peer trials
600 1st of 15 higher than 15 of 15 other Electronic Cigarette Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Electronic Cigarette Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Social Media Use on Young Adults' E-Cigarette Use
RECRUITING · NA
-
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
RECRUITING · NA
-
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
RECRUITING · Early Phase 1
-
Effect of Menthol on ENDS Users' Addiction and Exposure
RECRUITING · NA
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Effect of Cannabis on E-Cigarette Use Behavior
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI